Neuro42
Neuro42 is a San Francisco-based medical technology company that develops and sells FDA 510(k) cleared portable, low-field MRI systems with AI-powered image analysis and robotic intervention capabilities, serving neurosurgeons, stroke centers, and other healthcare facilities for point-of-care brain imaging.
- Company typePrivate
- Founded2021
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Neuro42 does
Neuro42 is a San Francisco-based medical technology company developing and commercializing a portable, low-field MRI platform combined with AI-powered image analysis and robotic intervention capabilities for neurological diagnosis and treatment. The core product is the FDA 510(k) cleared Diagnostic MRI Platform, a compact, low-field scanner intended for point-of-care neuroimaging at the bedside, in clinics, urgent care, or remote locations, with over 1,000 cumulative scans performed. The company is also developing an Interventional MRI Module that combines robotic assistance with live MRI guidance for procedures such as brain biopsies, ablations, and tumor resections, though this module is still pending regulatory clearance.
The company's business model is anchored on enterprise hardware sales of portable MRI systems to hospitals, stroke centers, urgent care, and skilled nursing facilities via a direct sales motion, supplemented by recurring service/support and potential subscription-based AI offerings, with quote-based, multi-year contracts. Neuro42 protects its platform with over 40 patents and technology rooted in Dr. Lawrence Wald's research at the Harvard/MGH Martinos Center. It serves primary customer segments of neurosurgeons, neuroradiologists, ER/stroke centers, and a secondary segment of sports organizations and athletes, with named reference accounts including Sutter Medical Center and Banner Health.
Since its founding in 2020/2021, Neuro42 has raised approximately $36.55 million in total funding across a Series A led by Zepp Health Corp., an NIH/NINDS grant, and ongoing securities offerings, while securing surgical robotics pioneer Fred Moll as a strategic advisor. The company operates with 11-50 employees and is led by President & CEO Amit Vohra, Chief Strategy Officer Abhita Batra, and Chief Development Officer Nikhil Sadhwani, with PhD-level SVPs heading MRI and robotics development.
Neuro42 firmographics
Firmographics- Name
- Neuro42
- Legal name
- Neuro42, Inc.
- Website
- https://neuro42.ai
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Neuro42 is a San Francisco-based medical technology company that develops and sells FDA 510(k) cleared portable, low-field MRI systems with AI-powered image analysis and robotic intervention capabilities, serving neurosurgeons, stroke centers, and other healthcare facilities for point-of-care brain imaging.
- Ownership category
- akta.pro rank
Neuro42 industry classification
Industry- Product category
- Medical Imaging Equipment
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Magnetic Resonance Imaging (MRI) Systems (HLAHABAC)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Neuro-oncology (HLAKAIAL)
Keywords
Where Neuro42 is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Neuro42 business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Portable MRI Hardware Sales: Sale of portable MRI systems to healthcare facilities including hospitals, stroke centers, urgent care, and skilled nursing facilities.
- Service and Support: Ongoing maintenance, support, and potentially subscription-based AI/software services for the MRI platform.
- Interventional Robotics Module: Future revenue stream from robotic intervention modules pending regulatory clearance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise medical imaging system - pricing available upon request |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Neuro42 product offering
Product offeringCore offering
Neuro42 develops and commercializes a portable, FDA 510(k) cleared low-field MRI scanner for point-of-care neuroimaging, combined with AI-powered image analysis and a robotic intervention module (pending regulatory clearance) for MRI-guided neurosurgical procedures such as brain biopsies, ablations, and tumor resections. The platform is designed to bring imaging to the bedside or clinic, reducing patient transport and accelerating diagnosis for stroke, brain lesions, and other neurological conditions.
Product overview
Neuro42 offers a portable MRI platform combining diagnostic imaging with AI-powered analysis and robotic-guided surgical intervention capabilities. The core product is the FDA 510(k) cleared Diagnostic MRI Platform, a portable low-field scanner for point-of-care neuroimaging. An add-on Interventional MRI Module (in development) enables MRI-guided robotic procedures. The company also operates a Sports Brain Health Partnership Program providing brain scanning services for athletes.
Differentiator
Problem solved
Functional benefit
Products and services
- Diagnostic MRI Platform FDA 510(k) cleared portable, low-field MRI scanner for point-of-care neuroimaging, enabling rapid bedside diagnosis of stroke and brain conditions at clinics, urgent care, and remote locations. Sold to hospitals, stroke centers, urgent care, and skilled nursing facilities.
- Interventional MRI Module MRI-guided robotic intervention system designed for neurosurgical procedures including brain biopsies, ablations, and tumor resections under live MRI guidance. Designed for neurosurgeons at hospitals and neurosurgical centers.
- Sports Brain Health Partnership Program Partnership program providing pre-game screening, baseline and post-game brain scans for athletes in high-impact sports including boxing, football, wrestling, and soccer. Targeted at sports leagues, trainers, and athletes.
Quantifiable outcome
- Reduced patient transportation - system brings imaging to patient rather than requiring transport
- +2 more outcomes
Companies that use Neuro42
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Neuro42 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
Neuro42 partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Lawrence Wald (Harvard/MGH)coreTechnology developed by Dr. Lawrence Wald's group at the Athinoula A. Martinos Center for Biomedical Imaging serves as the foundation for neuro42's portable MRI technology. Dr. Wald is a Professor of Radiology at Harvard and Biophysicist at MGH.
- National Brain Tumor SocietyminorPartnership with National Brain Tumor Society including participation in Miles for Milestones challenge that raised $950,000 for brain tumor research.
- Cris CyborgminorPartnership with UFC fighter Cris Cyborg for sports brain health initiatives and athlete brain monitoring programs.
- Barwis MethodsminorCollaboration with Barwis Methods athlete performance training organization for brain health and performance optimization programs.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Neuro42 competitors and assessment
Company assessmentDirect peers
- Hyperfine: Hyperfine develops the Swoop portable low-field MRI system for point-of-care brain imaging, the most direct head-to-head competitor to Neuro42's portable MRI platform with overlapping target customers (hospitals, ICUs, ERs) and similar FDA pathway.
- Promaxo: Promaxo builds office-based MRI systems for prostate and urological applications using a portable, AI-driven platform with similar miniaturization philosophy and clinical workflow positioning, and shares leadership overlap with Neuro42 (Promaxo developed by Abhita Batra's prior work).
- IMRIS: IMRIS provides intraoperative MRI systems that move into the OR for neurosurgical guidance, a directly comparable clinical use case (image-guided neurosurgery) to Neuro42's interventional module roadmap.
Emerging players
- Synaptive Medical: Synaptive Medical combines surgical robotics, intraoperative imaging, and AI for neurosurgery — overlapping with Neuro42's planned interventional MRI + robotics platform and competing in the same neurosurgical operating room workflow.
- Insightec: Insightec develops MR-guided focused ultrasound for non-invasive neurosurgery, overlapping with Neuro42's image-guided interventional ambition in the same neurosurgical patient population with a different (non-robotic) modality.
- Profound Medical: Profound Medical offers MR-guided transurethral ultrasound and other image-guided interventional platforms, sharing the playbook of combining imaging with therapeutic intervention in a single device workflow.
Broad incumbents
- GE HealthCare: GE HealthCare is one of the largest MRI manufacturers globally with broad hospital installed base and full radiology portfolio, representing the dominant incumbent that Neuro42 must displace or partner with for budget share.
- Siemens Healthineers: Siemens Healthineers offers a comprehensive MRI product line (including 0.55T low-field systems) plus AI image analysis — overlapping directly with Neuro42's diagnostic imaging value proposition as a scaled competitor.
- Philips Healthcare: Philips is a major MRI and image-guided therapy vendor with strong neurology and stroke care presence, the broadest incumbent competitive threat across both diagnostic and interventional use cases.
- Canon Medical Systems: Canon Medical manufactures MRI systems across field strengths and is an established hospital vendor in radiology, representing another large incumbent competing for imaging capital budgets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Neuro42 social profiles
Digital presenceNeuro42 compliance and trust
Trust signalCompliance1 record
Neuro42 financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neuro42 leadership team
Management profileNumber of profiles
Profiles5 records
Neuro42 funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neuro42 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neuro42
What does Neuro42 do?
Neuro42 develops and commercializes a portable, FDA 510(k) cleared low-field MRI scanner for point-of-care neuroimaging, combined with AI-powered image analysis and a robotic intervention module (pending regulatory clearance) for MRI-guided neurosurgical procedures such as brain biopsies, ablations, and tumor resections. The platform is designed to bring imaging to the bedside or clinic, reducing patient transport and accelerating diagnosis for stroke, brain lesions, and other neurological conditions.
Is Neuro42 a public or private company?
Neuro42 is a private company. It is classified as venture growth investor backed and is currently operating.
When was Neuro42 founded?
Neuro42 was founded in 2021. It employs 11 to 50 people.
Where is Neuro42 based?
Neuro42 is headquartered in San Francisco, United States, in the North America region.
How does Neuro42 make money?
Three revenue lines are on record. Portable MRI Hardware Sales are the primary driver. The others are service and Support and interventional Robotics Module.
Who are Neuro42's main competitors?
Direct peers on record are Hyperfine, Promaxo and IMRIS. Emerging players are Synaptive Medical, Insightec and Profound Medical. Broad incumbents are GE HealthCare, Siemens Healthineers, Philips Healthcare and Canon Medical Systems.
Does Neuro42 have an API?
No public API is recorded for Neuro42.
What industry is Neuro42 in?
Neuro42's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAC, Magnetic Resonance Imaging (MRI) Systems, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 339112 and its SIC code is 3841.